Bank of New York Mellon
CAMP icon

Bank of New York Mellon’s CAMP4 Therapeutics CAMP Stock Holding History

Bank of New York Mellon’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$365K Buy
83,421
+64,703
+346% +$279K ﹤0.01% 3897
2026
Q1 		$82.5K Hold
18,718
– – ﹤0.01% 4116
2025
Q4 		$115K Buy
+18,718
New +$79.6K ﹤0.01% 4097
2025
Q2 		– Sell
-13,118
Closed -$52.5K – 4156
2025
Q1 		$52.5K Buy
+13,118
New +$63.5K ﹤0.01% 4051

Other funds holding CAMP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Bank of New York Mellon's CAMP Position: Q2 2026 in Review

Bank of New York Mellon increased its CAMP4 Therapeutics (CAMP) stake by 346% in Q2 2026, buying an estimated $279K and bringing the position to 83,421 shares worth $365K. The position accounts for ﹤0.01% of the portfolio, ranked #3897.

Bank of New York Mellon first reported a position in CAMP in Q1 2025 and has held it in 4 quarters since. 18 funds tracked by Wall St. Rank hold CAMP as of Q2 2026.

  • Bank of New York Mellon held 83,421 shares of CAMP4 Therapeutics worth $365K as of Q2 2026.
  • Bank of New York Mellon bought 64,703 CAMP4 Therapeutics shares in Q2 2026, an estimated $279K.
  • CAMP4 Therapeutics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3897 holding.
  • Bank of New York Mellon first reported a position in CAMP4 Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • 18 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.